###begin article-title 0
###xml 71 75 <span type="species:ncbi:10090">Mice</span>
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: TM AP. Performed the experiments: TM AED MP. Analyzed the data: TM AED. Wrote the paper: TM AED AP.
###end p 1
###begin p 2
###xml 43 49 <span type="species:ncbi:9606">humans</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
Nitric oxide (NO) can induce acute pain in humans and plays an important role in pain sensitization caused by inflammation and injury in animal models. There is evidence that NO acts both in the central nervous system via a cyclic GMP pathway and in the periphery on sensory neurons through unknown mechanisms. It has recently been suggested that TRPV1 and TRPA1, two polymodal ion channels that sense noxious stimuli impinging on peripheral nociceptors, are activated by NO in heterologous systems. Here, we investigate the relevance of this activation. We demonstrate that NO donors directly activate TRPV1 and TRPA1 in isolated inside-out patch recordings. Cultured primary sensory neurons display both TRPV1- and TRPA1-dependent responses to NO donors. BH4, an essential co-factor for NO production, causes activation of a subset of DRG neurons as assayed by calcium imaging, and this activation is at least partly dependent on nitric oxide synthase activity. We show that BH4-induced calcium influx is ablated in DRG neurons from TRPA1/TRPV1 double knockout mice, suggesting that production of endogenous levels of NO can activate these ion channels. In behavioral assays, peripheral NO-induced nociception is compromised when TRPV1 and TRPA1 are both ablated. These results provide genetic evidence that the peripheral nociceptive action of NO is mediated by both TRPV1 and TRPA1.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Stamler1">[1]</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Lowenstein1">[2]</xref>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Meller1">[3]</xref>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Koesling1">[4]</xref>
###xml 705 708 705 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hess1">[5]</xref>
###xml 902 905 902 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hess1">[5]</xref>
###xml 906 909 906 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Ahern1">[6]</xref>
Nitric oxide (NO) is a gaseous signaling molecule generated from arginine and oxygen by nitric oxide synthases (NOS) [1]. NO plays essential roles in various biological processes including vascular signaling, immune responses, neurotransmission, and pain sensation/sensitization [2]-[3]. NO signaling is carried out by at least two separate pathways. In the first pathway, NO stimulates soluble guanylyl cyclase (sGC) to increase cyclic guanosine monophosphate (cGMP), which in turn modulates a variety of downstream signaling targets [4]. In the second pathway, NO covalently and reversibly forms adducts with free thiols of cysteine residues within proteins and hence directly modifies protein function [5]. Although functional significance of this S-nitrosylation has not been as well established as the NO-cGMP pathway, accumulating evidence suggests that it is a widespread mechanism of NO action [5]-[6].
###end p 4
###begin p 5
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Meller1">[3]</xref>
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Zochodne1">[7]</xref>
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Majewski1">[8]</xref>
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Vizzard1">[9]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Boettger1">[10]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Guhring1">[11]</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Meller2">[12]</xref>
###xml 865 869 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Meller2">[12]</xref>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Kitto1">[13]</xref>
###xml 1008 1011 1008 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Meller1">[3]</xref>
NO plays essential roles in development and maintenance of pain in response to inflammation and injury through its actions at both peripheral and central sites [3], [7]. NOS enzymes are expressed in peripheral sensory dorsal root ganglia (DRG) and central spinal cord neurons, and are upregulated during inflammation and injury [8]-[9]. The importance of NO production in inflammatory and neuropathic pain has been well documented through pharmacologic and genetic approaches [10]-[11]. Sensitization of central spinal cord neurons by NO contributes to hyperalgesia (increased sensitivity to painful stimuli) caused by inflammation and injury. For example, intrathecal administration of L-arginine (a substrate of NOS) induces hyperalgesia [12], while intrathecal administration of NOS blockers or NO scavengers block NMDA-induced hyperalgesia and neuropathic pain [12]-[13]. The mechanism of NO action on central spinal cord neurons in pain transmission is mainly dependent on the NO-cGMP signaling pathway [3].
###end p 5
###begin p 6
###xml 111 114 111 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Zochodne1">[7]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Holthusen1">[14]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Thomas1">[15]</xref>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Aley1">[16]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Ialenti1">[17]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hughes1">[18]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Tegeder1">[19]</xref>
###xml 185 191 <span type="species:ncbi:9606">humans</span>
In addition to modulating central neuronal activity, NO contributes to acute and chronic pain at the periphery [7]. For example, intracutaneous perfusion of NO causes pain sensation in humans [14]. Local NOS inhibition blocks chronic constriction injury (CCI)-induced neuropathic pain [15], prostaglandin E2-induced hyperalgesia [16] and paw edema caused by bradykinin or Substance P injection [17]-[18]. Furthermore, GTP cyclohydrolase, the rate-limiting enzyme for BH4 (tetrahydrobiopterin) synthesis, has been shown to regulate pain sensitivity and persistence in the periphery via BH4, an essential cofactor for NO production by NOS [19]. Remarkably, little is known about the molecular mechanism of NO's involvement in peripheral pain.
###end p 6
###begin p 7
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Yoshida1">[20]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Takahashi1">[22]</xref>
It has recently been suggested in heterologous systems that several members of the transient receptor potential (TRP) channels, including two peripherally-expressed polymodal nocisensors TRPV1 and TRPA1, are activated by NO donors [20]-[22]. However, thermoTRPs have proven to be promiscuous receptors, and determining a physiological relevance of TRP channel activation requires genetic or pharmacological evidence. Here, we investigated if the activation of the TRP ion channels by NO could underlie NO's involvement in peripheral pain, mainly focusing on primary sensory neurons and behavioral consequences of NO action.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Nitric Oxide Donor Activates Primary DRG Neurons
###end title 9
###begin p 10
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Holthusen1">[14]</xref>
###xml 764 774 752 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1A, B</xref>
###xml 779 786 767 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t001">Table 1</xref>
###xml 886 890 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 1049 1056 1035 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1C</xref>
###xml 1128 1135 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1C</xref>
###xml 1528 1535 1514 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1A</xref>
###xml 1636 1643 1622 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1A</xref>
###xml 1802 1805 1788 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Koesling1">[4]</xref>
###xml 1839 1843 1825 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Schmidtko1">[24]</xref>
###xml 2038 2042 2024 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Wei1">[25]</xref>
###xml 2044 2051 2030 2037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1C</xref>
###xml 2387 2394 2373 2380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g001">Fig. 1C</xref>
###xml 2400 2407 2386 2393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t001">Table 1</xref>
###xml 78 84 <span type="species:ncbi:9606">humans</span>
NO, presumably through direct activation of nociceptors, causes acute pain in humans [14]. We thus sought to determine if NO activates cultured DRG neurons using compounds that spontaneously release NO. To assay large numbers of neurons simultaneously, we used ratiometric calcium imaging which detects global changes in cytoplasmic calcium levels and assesses both direct (e.g., modulation of a putative calcium-permeable NO receptor) and indirect (e.g., release of calcium from intracellular stores and/or downstream activation of calcium-permeable ion channels) processes. Interestingly, we observed intracellular calcium increase in approximately approximately30% of total neurons upon application of the NO donor SNAP (S-nitroso-N-acetylpenicillamine; 3 mM) (Fig. 1A, B and Table 1). Lower concentrations of SNAP (</=1 mM) did not significantly alter calcium levels in DRG neurons [23]. A congener of SNAP lacking the releasable NO group (NAP: N-acetylpenicillamine; 3 mM) did not activate DRG neurons, consistent with NO-dependent activation (Fig. 1C). SNAP had little effect in the absence of extracellular calcium ions (Fig. 1C), suggesting that the signal was largely due to influx of calcium through calcium-permeable ion channels. Based on the kinetics of SNAP-evoked activation, we defined two apparently distinct populations of neurons activated by SNAP by setting arbitrary thresholds: those revealing a significant increase in intracellular calcium within one minute after SNAP application ("fast-SNAP+" neurons, Fig. 1A left, 1B blue), and those exhibiting a significant increase after one minute ("slow-SNAP+" neurons, Fig. 1A right, 1B red). Soluble guanylyl cyclase (sGC), a well-characterized molecular target of NO which causes an increase in intracellular cGMP in many cell types [4], is not expressed in DRG neurons [24]. We confirmed that NO donor activates DRG neurons in a cGMP-independent manner using the membrane-permeable cGMP analogue pCPT-cGMP (8-(4-Chlorophenylthio)-guanosine 3',5'-cyclic monophosphate) [25] (Fig. 1C). We next tested whether TRP channels might mediate the NO donor-induced calcium response in DRG neurons by determining the sensitivity of the response to the non-selective TRP channel antagonist, ruthenium red (RR). RR almost completely blocked the NO donor-induced increase in calcium levels when applied before application of SNAP (Fig. 1C, and Table 1). These results suggest that NO released from SNAP activates a subset of DRG neurons through RR-sensitive ion channel(s).
###end p 10
###begin title 11
NO donor activates primary cultured DRG neurons.
###end title 11
###begin p 12
(A, B) Responses of primary cultured DRG neurons assessed by ratiometric calcium imaging. Fluorescent ratios (F340/F380) of individual neurons (A) and averaged traces (B) are shown. Fast-SNAP+ neurons display significantly increased intracellular calcium upon NO donor application within one minute (blue traces), and slow-SNAP+ neurons after one minute (red traces). Neurons without significant increases in intracellular calcium are also shown (B, green trace). Proportions of fast- and slow-SNAP+ in (B) are shown as percentages. DRG neurons were challenged with SNAP (3 mM) for 5 min (green bar). Capsaicin (Caps, 10 microM, red bar) was applied at the end as a control. (C) Summary of responses of primary cultured DRG neurons assessed by ratiometric calcium imaging. Proportions of neurons activated by SNAP (three left columns; subdivided into fast-SNAP+ (blue) and slow-SNAP+ (red) responders), and pCPT-cGMP (2 mM) and NAP (3 mM; non-NO releasing isomer of SNAP) (two right black columns) are shown. SNAP induced intracellular calcium responses were sensitive to Ruthenium red ("with RR") and required extracellular calcium ("0 Ca(ext)"). Cells were exposed to RR (10 microM) and calcium depleted saline 3 min prior to and throughout SNAP application and washed out prior to capsaicin addition. The proportion responsive to capsaicin was normal in these experiments.
###end p 12
###begin title 13
NO donor activates DRG neurons via TRPV1 and TRPA1.
###end title 13
###begin p 14
###xml 172 175 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 182 185 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 196 199 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 204 207 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 211 214 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 217 220 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Summary of the percent of responsive cultured DRG neurons to SNAP (3 mM), capsaicin (10 microM), and mustard oil (0.5 mM) from wildtype (with or without antagonists), TRPV1-/-, TRPA1-/-, and TRPV1-/-TRPA1-/- (V1-/- A1-/-) animals.
###end p 14
###begin p 15
Ruthenium Red (10 microM), BCTC (1 microM), or AP-18 (100 microM) were applied 3 min prior to SNAP application until SNAP washout.
###end p 15
###begin p 16
ATP (100 microM) was applied in the last of the experiment as a positive control. Approximately 20% of total DRG neurons were activated by application of ATP.
###end p 16
###begin title 17
TRPV1 and TRPA1 Are Directly Activated by NO Donors
###end title 17
###begin p 18
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hinman1">[26]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Salazar1">[28]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hinman1">[26]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Yoshida1">[20]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Takahashi1">[22]</xref>
We next sought to identify the molecular target(s) of NO donors within DRG neurons. TRPV1 and/or TRPA1 are prime candidate receptors, as they are expressed in nociceptors, are blocked by RR, and are known to be sensitive to reactive chemicals via covalent modification of cysteine residues [26]-[28]. Arguing against this, Hinman et al. stated that NO does not activate TRPA1 [26]. However, activation of recombinant TRPA1 and TRPV1 by NO donors in calcium imaging experiments has recently been reported [20]-[22]. Therefore, we re-examined if recombinant TRPV1 and/or TRPA1 could serve as molecular sensors for NO.
###end p 18
###begin p 19
###xml 109 116 109 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g002">Fig. 2A</xref>
###xml 299 309 299 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g002">Fig. 2B, C</xref>
###xml 557 564 555 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g002">Fig. 2E</xref>
###xml 672 676 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 192 197 <span type="species:ncbi:9606">Human</span>
SNAP at 2 mM increased intracellular calcium in Chinese Hamster Ovary (CHO) cells expressing TRPV1 or TRPA1 (Fig. 2A). SNAP produced a concentration-dependent activation of TRPV1 and TRPA1 in Human Embryonic Kidney (HEK293T) cells in experiments using the fluorometric imaging plate reader (FLIPR) (Fig. 2B, C). Due to the presence of a large background response to >5 mM SNAP, we were unable to obtain full concentration-response curves (but see response curve for NOR3: (+/-)-(E)-Ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide, another NO donor, below, Fig. 2E). Activation of heterologously-expressed TRPV1 and TRPA1 by SNAP (up to 4 mM) was completely blocked by RR [23].
###end p 19
###begin title 20
NO donors induce calcium influx in cells expressing TRPV1 or TRPA1.
###end title 20
###begin p 21
(A) SNAP (2 mM) increases intracellular calcium (F340/F380) in rTRPV1- and hTRPA1-expressing CHO cells (black and grey lines, respectively) but not YFP-positive mock transfected CHO cells (dashed line). Capsaicin (1 microM), mustard oil (250 microM), or ATP (100 microM) was applied as a control ("CTRL") for TRPV1-, TRPA1-expressing, or mock-transfected cells, respectively. Averages of at least 30 cells are shown. (B, C) Concentration-dependence of SNAP responses in rTRPV1- (B) and hTRPA1- (C) expressing HEK293T cells obtained by FLIPR. a.u.: arbitral unit. (D-G) Normalized concentration response curves to SNAP (D), NOR3 (E), menthol (F), and iodoacetamide (G) of HEK293T cells transiently expressing hTRPA1 (black) and C665S hTRPA1 (grey) determined by FLIPR.
###end p 21
###begin p 22
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Stamler1">[1]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hinman1">[26]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Salazar1">[28]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hinman1">[26]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Macpherson1">[27]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Karashima1">[29]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 1490 1499 1490 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g002">Fig. 2D&#8211;G</xref>
###xml 1826 1830 1826 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 1887 1891 1887 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Ford1">[30]</xref>
###xml 1977 1981 1977 1981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hu1">[31]</xref>
###xml 2100 2104 2100 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 2110 2120 2110 2120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
NO is known to reversibly form covalent adducts to free thiol groups of cysteine residues via S-nitrosylation [1]. TRPA1 and TRPV1 are both activated by electrophilic molecules through covalent modification of cysteine residues in the N-terminus [26]-[28]. We next investigated whether cysteine residues of TRPA1 are required for NO donor-dependent activation. Three cysteines and a lysine in the N-terminal region have been implicated in responses to reactive chemicals [26]-[27]. We therefore tested whether these residues are required for NO activation of TRPA1. As expected, both the triple cysteine ("3C": C621S, C641S, C665S) and the 3C with single lysine ("3CK"and additional K710R) TRPA1 mutants revealed decreased sensitivity to the cysteine alkylating reagent iodoacetamide (IA) as well as SNAP [23]. However, we found the sensitivity of these clones to the non-reactive agonists menthol [29] and 2-APB (2-Aminoethoxydiphenyl borate) to be moderately (3C) or severely (3CK) compromised [23]. In an attempt to identify TRPA1 mutants that have specific deficits in sensitivity to reactive chemicals (NO donors and/or IA) but not non-reactive agonists (i.e., with little/no general defects in overall channel function), we generated the three described individual cysteine mutants of TRPA1. Compared to wildtype TRPA1, C665S showed markedly right-shifted responses to two chemically distinct NO donors (SNAP and NOR3) and IA, while displaying relatively normal responses to menthol (Fig. 2D-G). This suggests that NO donor-evoked responses are at least partly modulated through cysteine 665, although clearly other residues/mechanisms are also involved. C621S showed relatively normal responses to SNAP, while C641S showed slightly decreased sensitivity to both NO donor and menthol, and thus is difficult to interpret [23]. Since histidines and cysteines are prime targets of NO [30], we also tested TRPA1 mutants with every histidine and cysteine individually mutated [31]. However, we found no additional residues specifically required for responses to NO but not for non-reactive agonists [23] (see Discussion).
###end p 22
###begin p 23
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hinman1">[26]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Salazar1">[28]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Bandell1">[32]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Yoshida1">[20]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Salazar1">[28]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Xu1">[33]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 620 630 620 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Yoshida1">[20]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Dhaka1">[34]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
While TRPA1 appears to be indiscriminately activated by most reactive chemicals, TRPV1 is less promiscuous [26]-[28], [32]. For TRPV1, C157 is reported to be required for allicin activation; and C616 and C621 (in the putative pore region) are proposed to be required for NO donor activation [20], [28], (however, also see [33]). We found that NO was still able to activate TRPV1-C157. Furthermore, the TRPV1 mutants;C616W:C621S (double cysteine mutant), C616A, and C621A each revealed normal NO donor-induced responses when normalized to capsaicin responses [23], contrary to the findings of Yoshida and colleagues (see Discussion) [20]. We also tested TRPV1 mutants with mutated histidine residues [34], but none of them showed specific deficits to SNAP [23].
###end p 23
###begin p 24
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 633 643 633 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">Fig. 3A, C</xref>
###xml 743 753 743 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">Fig. 3A, D</xref>
###xml 856 866 856 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">Fig. 3A, E</xref>
###xml 1060 1067 1060 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">Fig. 3B</xref>
###xml 1449 1459 1449 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">Fig. 3F, G</xref>
To verify our calcium imaging results, and to address whether NO-activation is membrane delimited, we next used electrophysiological methods to directly determine whether SNAP could activate recombinant TRPA1 and TRPV1. Initially we monitored TRPV1 and TRPA1 channel activity in the cell-attached configuration which minimally disrupts the intracellular milieu of the cell in the absence and presence of extracellularly applied 2.5-3 mM SNAP. In accordance with calcium imaging and FLIPR experiments, TRPA1 channel activity was significantly enhanced 5.7-fold (p<0.0001; One sample t-test) in 84% of patches during exposure to SNAP (Fig. 3A, C). SNAP also increased TRPV1 activity in this configuration by 2.5-fold (p<0.05) in 67% of patches (Fig. 3A, D). Vector transfected cells revealed no detectable change in outward current (i.e., fold change  = 1) (Fig. 3A, E). Prolonged exposure to the non-NO releasing congener of SNAP (NAP; 3 mM) elicited no change in TRPA1 and TRPV1 channel activity for at least twice the average latency to observe SNAP effects (Fig. 3B; p>0.2 for TRPA1 and p>0.7 for TRPV1). To determine whether cytoplasmic constituents were required for SNAP-dependent activation, we recorded from TRPA1 and TRPV1 in excised inside-out patches in the absence of GTP (guanosine-5'-triphosphate). Robust activation of both TRPA1 (n = 3; 8.5+/-2.7 fold) and TRPV1 (n = 2; 3.6 and 7.2 fold) were clearly observed in this configuration (Fig. 3F, G). These results support the hypothesis that TRPV1 and TRPA1 are directly activated by NO.
###end p 24
###begin title 25
NO donor directly activates TRPV1 and TRPA1.
###end title 25
###begin p 26
###xml 885 906 885 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1084 1091 1084 1091 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pipette</sub>
###xml 1330 1337 1330 1337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pipette</sub>
SNAP (3 mM) increases TRP channel activity in cell-attached (A-E) and excised inside out patches (F, G). (A, B) The average fold change induced by SNAP (3 mM) (A) or by the inactive congener NAP (3 mM) (B) in cell-attached patches expressing TRPA1 (n = 11 for (A), n = 4 for (B)), rTRPV1 (n = 4 for (A), n = 3 for (B)) and endogenous channels from YFP-positive vector transfected cells ("Vector only"; n = 3) is shown. Quantification of SNAP induced currents involved taking the difference between the averaged current obtained at a single voltage for all traces before and during SNAP application and the basal current level determined by averaging blank sweeps containing no TRP activity) during these same periods. The fold increase in current induced by SNAP is the leak subtracted SNAP-induced current normalized to the leak subtracted control current prior to SNAP addition (see Materials and Methods for more detail). (C) A cell-attached patch containing at least five hTRPA1 channels was challenged with a step depolarization from the resting membrane potential (near 0 mV) (Vpipette from +50 to -100 mV). Cell was exposed to SNAP (3 mM) beginning at the arrow (green traces);latency was 40 sec. (D) A cell-attached patch containing at least three rTRPV1 channels was challenged with a voltage ramp from -120 to +180 mV (Vpipette from +120 to -180 mV) over 300 msec to visualize voltage-gated channel activity. Cell was exposed to NAP (3 mM, grey sweeps) initially and then SNAP (3 mM, green) at the time indicated by the green arrow. (E) A YFP-positive HEK293T cell expressing vector was challenged. No TRP-like SNAP-induced channel activity was observed over 2 min. Cartoon of experimental protocol is shown. (F, G) SNAP (3 mM) activated hTRPA1 (F) and rTRPV1 (G) in excised inside out patches. Cartoon of experimental protocol is shown. The inset in (G) shows currents in the boxed area at higher gain to indicate that the activity is consistent with the gating of at least 6 single channels. n.s. not significant.
###end p 26
###begin title 27
NO Donor Activates DRG Neurons via TRPV1 and TRPA1
###end title 27
###begin p 28
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Petrus1">[35]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Valenzano1">[36]</xref>
###xml 576 583 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4A</xref>
###xml 588 595 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t001">Table 1</xref>
###xml 1048 1052 1040 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Macpherson1">[27]</xref>
###xml 1054 1058 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Bandell2">[37]</xref>
###xml 1195 1199 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Caterina1">[38]</xref>
###xml 1859 1863 1831 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 2331 2335 2303 2307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Story1">[39]</xref>
Since either TRPV1 or TRPA1 could mediate NO donor-induced calcium influx into DRG neurons, we first tested whether specific antagonists for TRPA1 (AP-18: (Z)-4-(4-chlorophynyl)-3-methylbut-3-en-2-oxime, [35]) and TRPV1 (BCTC: N-(4-t-Butylphenyl)-4-(3-Chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide, [36]) could inhibit DRG activation by SNAP. Interestingly, the slow-SNAP+ population (red bars) was specifically and dramatically reduced by the TRPA1 antagonist AP-18 (100 microM), while the fast-SNAP+ population was reduced by the TRPV1 antagonist BCTC (1 microM) (Fig. 4A and Table 1). AP-18 appeared to have little if any effect on the fast-SNAP+ population, while BCTC had little effect on the slow-SNAP+ population. These results suggest that TRPA1 and TRPV1 mediate slow-SNAP+ and fast-SNAP+ responses, respectively, demonstrating that native TRPV1 and TRPA1 are each required for normal NO sensing. The slow-onset and sustained intracellular calcium increase of NO-induced responses have been observed for TRPA1 in calcium imaging [27], [37]. Also note that the fast-SNAP+ population (approximately10%) is significantly less than capsaicin-responsive population (usually 25-50% [38]), suggesting that SNAP only activates a subset of TRPV1-positive neurons (presumably, those expressing high TRPV1 levels). Most fast-SNAP+ cells (73.4+/-8.6%) displayed significant increases in intracellular calcium to capsaicin while significantly fewer (28.9+/-5.6%) slow-SNAP+ responded to capsaicin. Also, the average magnitude of the capsaicin responses were 2.0+/-0.1 fold (fast-SNAP+) and 1.3+/-0.1 fold (slow-SNAP+) (p<0.005), consistent with slow-SNAP+ responders having smaller capsaicin sensitivity after SNAP exposure (we did not observe any difference in the latency of SNAP-induced activation between slow-SNAP+ Caps+ and slow-SNAP+ Caps- cells [23]). A number of possible explanations could account for this difference including lower TRPV1 expression and/or enhanced tachyphylaxis of TRPV1 in this population. It should also be noted that TRPA1-mediated slow-SNAP+ neurons do not display fast activation, suggesting that TRPV1 functionality is not sufficient (presumably due to low TRPV1 levels) to be activated (at detectable levels) by SNAP in TRPA1-positive neurons, even though TRPA1 and TRPV1 are co-expressed [39].
###end p 28
###begin title 29
NO donor activates DRG neurons via TRPV1 and TRPA1.
###end title 29
###begin p 30
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 188 191 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 398 405 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t001">Table 1</xref>
###xml 668 675 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t002">Table 2</xref>
###xml 742 746 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Kwan1">[58]</xref>
###xml 747 751 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Bautista1">[59]</xref>
Proportion (%) of neurons activated by SNAP (3 mM) is shown and characterized as fast-SNAP+ (blue) and slow-SNAP+ (red) in different genetic backgrounds (e.g., A1-/- V1-/- represents TRPA1-/- TRPV1-/-) and treatments. (A) DRG neurons were challenged with SNAP (3 mM) for 5 min, followed by capsaicin (Caps, 10 microM), mustard oil (MO, 0.5 mM), and/or ATP (100 microM) as controls (n>/=4 each, see Table 1 for quantitation). AP-18 (100 microM) and BCTC (1 microM) were applied 3 min prior to SNAP application. (B) DRG neurons were first pretreated with forskolin (100 microM) and m-3M3FBS (50 microM) for 10 min, followed by the same protocol as (A). (n>/=7 each, see Table 2 for quantitation). Haploinsufficiency has been reported for TRPA1 [58]-[59] when monitoring certain phenotypes and may influence the proportion of slow-SNAP+ neurons observed in our cultures.
###end p 30
###begin p 31
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4A</xref>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t001">Table 1</xref>
###xml 371 374 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4A</xref>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t001">Table 1</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4A</xref>
###xml 601 607 601 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g002">Fig. 2</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">3</xref>
###xml 677 680 677 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Akopian1">[40]</xref>
###xml 973 980 973 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4A</xref>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
To further confirm the results with specific antagonists, we performed calcium imaging experiments on primary DRG neurons from TRPV1- and/or TRPA1-deficient animals. As expected, the slow-SNAP+ population was specifically compromised in TRPA1-/- DRG neurons (Fig. 4A and Table 1). Unexpectedly, however, both fast and slow SNAP+ populations were virtually absent in TRPV1-/- DRG neurons (Fig. 4A and Table 1), in apparent contradiction to the pharmacological study using BCTC (Fig. 4A, Wildtype + BCTC), and to our observation that TRPA1 is responsive to NO donors in heterologous expression systems (Fig. 2, 3). These results could be explained if TRPA1 functionality in TRPV1-/- DRG neurons is compromised due to lack of constitutive TRPV1 activity. Indeed, it has been recently reported that constitutive TRPV1 activity plays a role in stabilizing TRPA1 expression [40]. Not surprisingly, mice lacking both TRPV1 and TRPA1 also showed a virtual absence of NO responses (Fig. 4A).
###end p 31
###begin p 32
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Wang1">[41]</xref>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Bae1">[42]</xref>
###xml 672 675 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 681 684 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 695 702 695 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4B</xref>
###xml 707 714 707 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t002">Table 2</xref>
###xml 822 825 822 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 831 834 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 898 905 898 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4B</xref>
###xml 910 917 910 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t002">Table 2</xref>
###xml 1006 1009 1006 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1015 1018 1015 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1149 1155 1149 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g004">Fig. 4</xref>
As TRPA1 appears less functional in TRPV1-/- DRG neurons, we reasoned that sensitizing TRPA1 might enable us to observe TRPA1-dependent NO responses in TRPV1-/- DRG neurons. Since PKA and PLC signaling pathways are reported to sensitize TRPA1 responses in heterologous systems [41], we attempted to sensitize TRPA1 in TRPV1-/- DRG neurons by incubating DRG neurons with the PKA activator forskolin and PLC activator m-3M3FBS (N-(3-Trifluoromethylphenyl)-2,4,6-trimethylbenzenesulfonamide; [42]) prior to SNAP application. Remarkably, after incubation with forskolin and m-3M3FBS, we were able to observe the slow-SNAP+ population in DRG neurons from TRPV1-deficient (TRPA1+/- TRPV1-/-) animals (Fig. 4B and Table 2). The slow-SNAP+ population was absent but the fast-SNAP+ population was retained in TRPA1-deficient (TRPA1-/- TRPV1+/-) animals, confirming that the fast-SNAP+ is mediated by TRPV1 (Fig. 4B and Table 2). Almost-complete reduction in SNAP+ neurons in TRPV1/A1-double deficient animals (TRPA1-/- TRPV1-/-) suggest that these two ion channels account for calcium influx induced by SNAP, which is the main conclusion from these studies (Fig. 4).
###end p 32
###begin title 33
PKA and PLC pathways sensitize TRPA1 to NO donor.
###end title 33
###begin p 34
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Summary of the percent of responsive "sensitized" DRG neurons to SNAP (3 mM), capsaicin (10 microM), and mustard oil (0.5 mM) from mice of the indicated genotypes (V1 represents TRPV1 and A1 represents TRPA1). DRG neurons were incubated with forskolin (100 microM) and m-3M3FBS (50 microM) for 10 min prior to SNAP application.
###end p 34
###begin p 35
ATP (100 microM) was applied in the last of the experiment as a positive control. Approximately 20% of total DRG neurons were activated by application of ATP.
###end p 35
###begin title 36
Endogenous NO Activates DRG Neurons via TRPV1 and TRPA1
###end title 36
###begin p 37
###xml 151 161 151 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Tegeder1">[19]</xref>
###xml 613 614 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 614 619 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#969;</sub>
###xml 701 702 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 702 707 686 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#969;</sub>
###xml 810 817 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g005">Fig. 5A</xref>
###xml 822 829 802 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t003">Table 3</xref>
###xml 851 855 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Tegeder1">[19]</xref>
###xml 945 948 925 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 954 957 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 971 978 951 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g005">Fig. 5B</xref>
###xml 983 990 963 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t003">Table 3</xref>
###xml 1184 1191 1164 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g005">Fig. 5C</xref>
One criticism of the above experiments is that we are using high levels of NO donors, and that these levels are not physiologically relevant (also see Discussion). We therefore investigated whether TRPV1 and TRPA1 can be activated by endogenously-produced NO. BH4 (tetrahydrobiopterin), an essential cofactor for NO production by NOS, is known to increase intracellular calcium in DRG neurons at least partly in a Nitric Oxide Synthase (NOS)-dependent manner [19]. We observed that approximately15% of total DRG neurons displayed an increase in intracellular calcium upon BH4 (1 mM) application, and that L-NAME (Nomega-Nitro-L-arginine methyl ester hydrochloride) but not its inactive isomer D-NAME (Nomega-Nitro-D-arginine methyl ester hydrochloride) blocked the BH4-induced intracellular calcium increases (Fig. 5A and Table 3) as shown previously [19]. Importantly, the increase in intracellular calcium by BH4 is essentially absent in TRPV1-/- TRPA1-/- DRG neurons (Fig. 5B and Table 3), whereas BH4-induced production of NO levels were comparable between two genotypes as determined by the NO-sensitive fluorescence dye DAF-FM (4-amino-5-methylamino-2',7'-difluorofluorescein) (Fig. 5C). The most straightforward conclusion from these studies showing the specific NOS inhibitor blocks BH4-mediated calcium increase is that TRPV1 and TRPA1 can be activated by endogenously-generated NO. However, it cannot be excluded that BH4's action on other pathways might play a role in increasing calcium levels.
###end p 37
###begin title 38
BH4 activates DRG neurons via TRPV1 and TRPA1.
###end title 38
###begin p 39
###xml 203 206 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 211 214 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 236 239 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 244 247 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 251 254 247 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sub>
###xml 256 259 252 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sub>
###xml 441 448 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007596-t003">Table 3</xref>
Proportion (%) of neurons activated by BH4 (1 mM) is shown. (A) DRG neurons pretreated with either L-NAME or D-NAME (200 microM, n = 7 each) were challenged with BH4 for 3 min. (B) DRG neurons from TRPA1+/-TRPV1+/- (A1+/-V1+/-) or TRPA1-/-TRPV1-/- (A1-/-V1-/-) animals were challenged with BH4 (1 mM) for 3 min. Capsaicin (10 microM) or ATP (100 microM) were applied at the end of the experiment as controls (n = 6 separate experiments, see Table 3 for quantitation). (C) Increases (%) in DAF fluorescence of DRG neurons of indicated genotypes are shown (n = 3 separate experiments comparing each genotype).
###end p 39
###begin title 40
Endogenous NO activates DRG neurons via TRPV1 and TRPA1.
###end title 40
###begin p 41
###xml 203 207 <span type="species:ncbi:10090">mice</span>
Summary of the percent of responsive DRG neurons to BH4 (1 mM), capsaicin (10 microM), mustard oil (0.5 mM), and ATP (100 microM) with indicated treatment (D-NAME or L-NAME, both at 200 microM), or from mice of indicated genotypes (V1 represents TRPV1 and A1 represents TRPA1).
###end p 41
###begin title 42
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
NO Donors Cause Pain via TRPV1 and TRPA1 In Vivo
###end title 42
###begin p 43
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-1">[23]</xref>
###xml 475 484 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Figure 6A</xref>
###xml 685 694 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Figure 6A</xref>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
We next investigated whether peripheral nociceptive actions of NO require TRPV1 and TRPA1. Intraplantar injection of NO donors (SNAP at 25 mM, NOR3 at 1.5 mM, NOC7: 3-(2-Hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine at 25 mM, or glyceryl trinitrate at 0.5 mg/ml) did not evoke significant acute pain behavior compared to vehicle responses [23]. However, intraplantar injection of SNAP (25 mM) induced thermal (but not mechanical) hyperalgesia in wildtype mice (Figure 6A, leftmost set of bars). TRPV1 is known to be required for induction of thermal hyperalgesia in response to a variety of stimuli. Indeed, SNAP-induced thermal hyperalgesia was largely TRPV1-dependent (Figure 6A).
###end p 43
###begin title 44
NO donors induce TRPV1-dependent thermal hyperalgesia and nocifensive behavior upon sensitization via TRPV1 and TRPA1.
###end title 44
###begin p 45
###xml 660 663 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 682 685 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 701 704 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 707 710 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1137 1140 1125 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1143 1146 1131 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">Mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1438 1442 <span type="species:ncbi:10090">mice</span>
(A) Normalized changes in paw withdrawal latency are shown in response to a heat stimulus (average of three stimuli) 30 min after SNAP injection (25 mM in PBS, 1% DMSO). Decreases in paw withdrawal latency (%) were normalized to the value of SNAP-injected control mice (left columns) for each grouping (the larger the percentage, the faster the withdrawl to a heat stimulus). The first grouping represents SNAP- or vehicle- (1% DMSO) injected C57BL6 mice. The next three groupings show SNAP-induced thermal hyperalgesia in littermates with genotypes shown at bottom. Latencies of control animals were similar; 2.9+/-0.4 (SNAP-injected C57BL6), 2.7+/-0.3 (TRPV1+/+), 3.5+/-1.0 (TRPA1+/+), 3.4+/-0.6 (A1+/- V1+/-). (B, C) Nocifensive response duration (flicking, licking, and lifting injected paw) recorded over 10 min after injection of NO donors in the hindpaw. N>/=10 mice were tested (N>/=6 for vehicle controls). Mice were first injected with forskolin and m-3M3FBS (1 mM each) followed by NOC7 (25 mM) (B) or NOR3 (1.5 mM) (C) injection. Genotype of animals is indicated (A1: TRPA1, V1: TRPV1). Vehicle-injected control mice ((B): A1+/- V1+/- + vehicle: vehicle injection 5 min after first injection, (C):CTRL+NOR3 vehicle: vehicle injection 15 min after first injection, and CTRL+FSK/3M3FBS vehicle: first injected with vehicle for forskolin and m-3M3FBS followed by NOR3 injection 15 min after first injection) are also shown. CTRL mice in (C) share the same genetic background and carry at least one copy of wildtype TRPV1 and TRPA1; the first four columns represent results from littermates.
###end p 45
###begin p 46
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Fig. 6B</xref>
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Fig. 6C</xref>
###xml 723 733 723 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Fig. 6B, C</xref>
###xml 1207 1217 1207 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Fig. 6B, C</xref>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
Since acute pain was not observed after NO donor injection, we sought a protocol that would evoke NO donor-induced nociception after pharmacologically sensitizing nociceptors. Based on our DRG culture experiments, we tested whether pre-activation of PLC/PKA pathways could lead to NO donor-induced nocifensive behavior. After injection of forskolin and m-3M3FBS together (each at 1 mM), we observed significant nocifensive behavior upon injection of two chemically distinct NO donors (NOC7 (Fig. 6B) and NOR3 (Fig. 6C)) over background in wildtype animals. Remarkably, when we tested animals lacking TRPV1 and/or TRPA1, peripheral NO donor-induced pain behavior was compromised only when both TRPV1 and TRPA1 were ablated (Fig. 6B, C). This indicates that NO donor-induced nociception is dependent on both TRPV1 and TRPA1 (in another words, activation of either TRPV1 or TRPA1 by NO donors can cause acute pain after sensitization). We cannot say at this time if all NO-induced nociception is ablated in the double knockout mice, although the nocifensive response duration after vehicle injection in control animals is not statistically different from that after NO-donor injection in double knockout mice (Fig. 6B, C).
###end p 46
###begin title 47
Discussion
###end title 47
###begin title 48
Nitric Oxide Donors Activate TRPV1 and TRPA1
###end title 48
###begin p 49
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Yoshida1">[20]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Takahashi1">[22]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Nilius1">[43]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Malkia1">[44]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Karashima1">[29]</xref>
###xml 771 774 771 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hess1">[5]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hinman1">[26]</xref>
###xml 1774 1778 1774 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Hu1">[31]</xref>
###xml 1780 1784 1780 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Dhaka1">[34]</xref>
###xml 1786 1790 1786 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Fujita1">[45]</xref>
###xml 2133 2137 2133 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Macpherson1">[27]</xref>
Our studies provide genetic and pharmacological evidence that NO donors activate TRPV1 and TRPA1 both in heterologous systems and in naive DRG neurons. Previous calcium imaging studies on heterologously expressed TRPV1 and TRPA1 revealed NO donors evoked an increase in intracellular calcium levels dependent on channel expression [20]-[22]. It is presently not known whether the gating mechanism involves an NO-dependent shift in the voltage dependence of activation of TRPA1 and/or TRPV1, as demonstrated for TRPV1 and TRPM8 [43]-[44], and as shown for TRPA1 with regard to menthol dependent activation [29]. Regardless, NO appears to activate TRPV1 and TRPA1 through S-nitrosylation, which involves transfer of a nitric oxide group to cysteine sulfhydryls on proteins [5]. Consistent with this, we observe that C665, one of three TRPA1 cytoplasmic cysteines involved in responding to a variety of reactive chemicals [26], is also required for normal responsiveness to NO but not to the non-reactive agonist menthol implying that overall channel function of this mutation is not compromised. Although unlikely, we cannot rule out an indirect activation mechanism of TRPA1 via NO-induced formation of a membrane-delimited chemical or via other NO-activated redox-sensitive proteins (presumably present in detached patches of HEK293T, CHO, DRG cells). Furthermore, incomplete ablation of NO or iodoacetamide responses in single or triple TRPA1 cysteine mutations suggests that other mechanisms (residues) are also involved in sensing cysteine-reactive chemicals. Indeed, other amino acid residues (cysteines as well as histidines) of TRPA1 in addition to these three cysteines have recently been reported to be required for channel activation by zinc and intracellular base [31], [34], [45]. To date, how modification of cysteines in TRPA1 by reactive chemicals translates into channel activation is unknown. It is especially intriguing that activation appears to be independent of the shape of the chemical, or the type of the chemical reaction (alkylation, disulfide formation, Michael addition, nitrosylation, deprotonation etc.) [27]. It is possible that such reactions cause local or global conformational changes in the N-terminus cytoplasmic domain of TRPA1 that ultimately leads to channel gating.
###end p 49
###begin p 50
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Salazar1">[28]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Bandell1">[32]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-TaylorClark1">[46]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Yoshida1">[20]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Xu1">[33]</xref>
There is increasing evidence that TRPV1 is also activated by reactive chemicals. However, while TRPA1 is promiscuous and is activated by most reactive chemicals, only a subset of such chemicals appears to activate TRPV1 [28], [32], [46]. We found that the cytoplasmic cysteine responsible for allicin-activation of TRPV1 is not required for NO-induced activation. Yoshida et al. proposed a general mechanism that two conserved cysteine residues among TRPs (including TRPV1) are required for activation by NO [20]. This finding has recently been challenged by Xu et al. who show that reduction of disulfide bonds between these two residues activates TRPC channels [33]. Therefore, whether NO targets these two pore cysteines in TRP channels is not settled. We show here that at least for TRPV1, the two pore cysteines are not required for activation by NO donor. It is possible that the large number of cysteine (18 Cys per subunit) and histidine (12 His per subunit) residues in TRPV1 cooperatively function in NO-sensing. More mechanistic studies are required to elucidate exactly how NO (and reactive chemicals in general) activates TRPV1, TRPA1, and other TRP channels; however, the focus of our study is on the genetic requirement of thermoTRPs in peripheral NO signaling in pain (below).
###end p 50
###begin title 51
TRPV1 and TRPA1 Mediate Nociception in Response to Peripheral Nitric Oxide
###end title 51
###begin p 52
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Boettger1">[10]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Guhring1">[11]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Holthusen1">[14]</xref>
###xml 856 864 856 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 867 869 867 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 930 938 930 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 941 943 941 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1567 1575 1567 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1937 1944 1937 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2074 2078 2074 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Patapoutian1">[47]</xref>
###xml 2321 2325 2321 2325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Story1">[39]</xref>
###xml 2476 2480 2476 2480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Jeske1">[48]</xref>
###xml 2542 2546 2542 2546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Akopian1">[40]</xref>
###xml 221 227 <span type="species:ncbi:9606">humans</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 591 596 <span type="species:ncbi:9606">human</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
###xml 2117 2121 <span type="species:ncbi:10090">mice</span>
A role for peripherally-acting NO in hyperalgesia is supported by pharmacological data that NOS blockers relieve inflammatory and neuropathic pain in rodents [10]-[11]. Furthermore, NO donors cause acute moderate pain in humans, suggesting a role in acute nociception [14]. However, the behavioral consequences of direct peripheral application of NO donors have not been investigated in the mouse. Our studies reveal that NO donor injection in hindpaws causes TRPV1-dependent thermal hyperalgesia without causing significant acute pain behavior. These data suggest that direct comparison of human and rodent pain behavior is untenable and may point to a difficulty in assessing moderate pain in rodents. Note that due to solubility issues of NO donors, we were limited to using relatively low levels of NO donors for behavioral experiments (< ten fold the in vitro EC50). For capsaicin, injections of capsaicin at >1000 times the in vitro EC50 are typically used to observe acute pain behavior. Therefore, it is not surprising that significant acute nocifensive behavior was not observed, but only hyperalgesia. Regardless, we show that after PLC and PKA pathway activation (which sensitizes nociceptors, including TRPV1 and TRPA1 - see below), injections of two chemically distinct NO donors in the paw cause nociceptive behavior. Importantly, the NO donor-dependent nocifensive behavior required both TRPV1 and TRPA1, as we observed a decrease in nociception in mice lacking both TRPV1 and TRPA1, but not in individual knockout animals. This is consistent with our in vitro results showing that NO donors can activate both ion channels, and our DRG culture experiments, where we observe both TRPA1- and TRPV1-mediated responses. The most parsimonious explanation of these results is that NO's behavioral consequences is due to direct activation of these thermoTRPs; however, it cannot be ruled out that NO also targets TRPV1 and TRPA1 in vivo through indirect mechanisms. TRPV1 and TRPA1 are each well-characterized to be required for sensing a variety of noxious stimuli [47]; this is the first demonstration that mice lacking both genes have a shared requirement to respond to a specific stimulus, and therefore have overlapping functions. These two nocisensors have overlapping expression in a subset of DRG neurons [39] and thereby could potentially interact via intracellular signaling. Previous studies have shown that robust activation of TRPV1 can desensitize TRPA1 [48], but also that TRPV1 is required for proper TRPA1 expression [40]. These results point to elaborate communications between these two nocisensors.
###end p 52
###begin title 53
Potential Physiological Roles of NO-Induced TRPV1/TRPA1 Activation
###end title 53
###begin p 54
###xml 142 149 142 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Fig. 6A</xref>
###xml 222 232 222 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">Fig. 6B, C</xref>
###xml 479 482 479 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Majewski1">[8]</xref>
###xml 483 486 483 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Vizzard1">[9]</xref>
###xml 645 648 645 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Lowenstein1">[2]</xref>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-CalsGrierson1">[49]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-TaylorClark2">[50]</xref>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Tegeder1">[19]</xref>
###xml 1121 1127 1121 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g005">Fig. 5</xref>
###xml 1642 1646 1642 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Pietrobon1">[51]</xref>
###xml 1647 1651 1647 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Chizh1">[52]</xref>
###xml 1680 1684 1680 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Calabrese1">[53]</xref>
###xml 1685 1689 1685 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Gibson1">[55]</xref>
###xml 1721 1725 1721 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Birder1">[56]</xref>
Behavioral assays involving NO performed in this study are linked to peripheral sensitization: in one, NO donor causes thermal sensitization (Fig. 6A); in the other, sensitization reveals a nociceptive role for NO donors (Fig. 6B, C). Hence, the behavioral results highlight a physiological role of peripheral NO preferentially in the sensitized or hyperalgesic state. Indeed, NOS genes are known to be expressed in DRG neurons and are upregulated during inflammation and injury [8]-[9]. Moreover, macrophages, keratinocytes, and endothelial cells are known to release NO during inflammation, and are in close proximity to sensory nerve endings [2], [49]. Relevant to this, nitrooleic acid, an endogenous nitrated fatty acid which is generated during excessive NO production, was recently reported to covalently activate TRPA1 [50]. It is possible that NO and NO-derived compounds from many cell types act together on TRPV1 and TRPA1 during inflammation. Regardless, BH4-induced intracellular calcium increase in primary cultured DRG neurons is partly dependent on NOS [19], and essentially dependent on TRPV1 and TRPA1 (Fig. 5). It should be noted that we cannot exclude the possibility that BH4 acts on other pathways to regulate neuronal activity. Nevertheless, our results suggest that endogenous levels of NO are capable of activating thermoTRPs, and that TRPV1 and TRPA1 are involved in NO-dependent peripheral sensitization to pain. NO's action on TRPV1 and TRPA1 could potentially be relevant in other biological systems where NO and TRPV1/A1 have been implicated to be involved. This includes the trigeminovascular system (migraine) [51]-[52], synaptic plasticity in CNS [53]-[55], and relaxation in the bladder [56].
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
Ethics Statement
###end title 56
###begin p 57
All experiments involving animals were conducted with the approval of The Scripps Research Institute Animal Research Committee. All aspects of the program for procurement, conditioning/quarantine, housing, management, veterinary care, and disposal of carcasses follow the guidelines set down in the NIH Guide for Care and Use of Laboratory Animals.
###end p 57
###begin title 58
Cell Culture/Ratiometric Calcium Imaging/FLIPR
###end title 58
###begin title 59
Ratiometric calcium imaging
###end title 59
###begin p 60
For determination of threshold for activation in ratiometric calcium imaging, the magnitude of the ratio change during exposure to agonist was normalized to the baseline ratio (fold-change) for each imaged neuron. A histogram of the fold change of each individual neuron in a particular experiment was constructed for each stimulus to determine the threshold for activation. The multimodal histogram contained one large peak around 1 (defined as the background response) and neurons with fold-changes greater than the first minimum (defined as threshold) were considered responsive. For DRG neurons, at least 200 neurons were selected in each experiment and for transiently transfected CHO cells, at least 30 YFP-positive cells were selected.
###end p 60
###begin title 61
Primary DRG cultures
###end title 61
###begin p 62
###xml 151 156 <span type="species:ncbi:9796">Horse</span>
Extirpated thoracic and lumbar DRGs were dissociated by incubation for one hour at 37degreesC in a solution of culture medium (Ham's F12/DMEM with 10% Horse Serum, 1% penicillin-streptomycin) containing 0.125% collagenase (Worthington Biochemicals) followed by a 30 min incubation in 10 ml of culture media with 1.25 units papain. Cells were fully dissociated with a flame-polished pipette, and centrifuged (10 min, 1000 rpm, RT) with BSA column. Dissociated neurons were placed on poly-D-lysine/laminin Coated Glass Coverslips (BD Biosciences). Growth media was supplemented with 50 ng/ml nerve growth factor and 25 ng/ml glial cell line-derived neurotrophic factor.
###end p 62
###begin title 63
Transient transfection
###end title 63
###begin p 64
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
CHO or HEK293T cells were transiently transfected with plasmids encoding rat TRPV1 (rTRPV1), human (hTRPA1) or mouse (mTRPA1) TRPA1, and their mutants using FuGENE Transfection Reagent (Roche) according to manufacturer's instructions. CHO cells were used for ratiometric calcium imaging experiments since they are more adherent than HEK293T cells. HEK293T cells were used for FLIPR because of their high transfection efficiency and for electrophysiological experiments because they are more amenable to performing the different patch clamp configurations used in this study. For calcium imaging and electrophysiology, CHO or HEK293T cells were co-transfected with a pcDNA3-based YFP marker plasmid. Control cells were transfected with YFP vector alone. For FLIPR experiments, HEK293T cells were transiently transfected with plasmids using FuGENE Transfection Reagent without co-transfecting YFP marker plasmid.
###end p 64
###begin title 65
FLIPR (fluorometric imaging plate reader)
###end title 65
###begin p 66
For determination of concentration-response curves by FLIPR (Molecular Devices), HEK293T cells transiently transfected with plasmids encoding rTRPV1, hTRPA1, or their mutants were used. Two days after plating cells, cells were washed with assay buffer (1X Hanks' Balanced Salt Solution supplemented with 20 mM HEPES) and then loaded with Fluo-3 dye (Molecular Probes) according to manufacturer's instructions.
###end p 66
###begin p 67
To enable comparison between clones at different expression levels, all responses were normalized to the peak response to menthol (for TRPA1) or capsaicin (for TRPV1) for the same clone within the same experiment. Concentration response curves were fit using Igor Pro (WaveMetrics Inc.) with a Hill equation model. All data points represent mean +/- S.E.M.
###end p 67
###begin title 68
NO Imaging
###end title 68
###begin p 69
DRG neurons were loaded with DAF-FM deacetate (Invitrogen, 10 microM) for 20 min in the imaging buffer solution (1X Hanks' balanced salt solution (HBSS), 10 mM HEPES). Images of DAF-FM loaded cells with the excitation wavelength at 488 nm were captured with a LCD camera using MetaFluor (Universal Imaging Corp.). For direct comparison of results from different experiments, the fluorescence intensity of individual cells in each experiment was normalized to the baseline. At least 200 DRG neurons were imaged per experiment and normalized fluorescence intensities of individual neurons were averaged.
###end p 69
###begin title 70
Electrophysiology
###end title 70
###begin title 71
Cell-attached configuration of the patch clamp technique
###end title 71
###begin p 72
###xml 62 63 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 80 82 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 88 89 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 138 139 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 148 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 198 199 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 771 773 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 789 791 781 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 845 846 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 854 855 846 847 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were maintained at 25 degreesC in a high extracellular K+ saline ("2 mM Ca2+/HighK+-ES") containing (in mM): 136 KCl, 5 NaCl, 2 MgCl2, 2 CaCl2, 10 HEPES, pH 7.3 with NaOH. High extracellular K+ was used to shift the resting membrane potential toward 0 mV and avoid voltage dependent changes in TRP activity due to off target effects on endogenous background currents (the SNAP-induced conductances observed in whole cell experiments with HEK293T cells reversed at +15+/-5 mV, n = 3). The resting potential is likely to be close to zero since the reversal potentials of SNAP-induced TRPV1 and TRPA1 macroscopic or averaged currents were near zero in the cell-attach patch configuration when voltage ramp protocols were used. Pipettes were filled with either "0 mM Ca2+ ES" or "2 mM Ca2+ ES" (which contained (in mM): 136 NaCl, 5 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, pH 7.3 with NaOH) and had resistances of 3-15 Mohm when filled. Voltage ramp- or step-induced currents were acquired using the indicated protocols. Only patches containing relatively few channels were chosen for study in order to obtain blank sweeps during control and activated conditions. All data were acquired at 11.1 KHz and single channel records were filtered off-line at 3 KHz).
###end p 72
###begin title 73
Excised inside-out configuration of the patch clamp technique
###end title 73
###begin p 74
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 158 171 158 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8764;</bold>
###xml 296 297 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 363 365 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Voltage protocols were similar to those described for cell-attached patch experiments. Pipettes contained 2 mM Ca2+ ES. The bath was continuously perfused at approximately26degreesC with a Cs-aspartate based intracellular saline which contained (in mM): 154 L-aspartate, 5 NaCl, 5 EGTA, 0.08 CaCl2, 10 HEPES, 2 methanesulfonate, pH to 7.3 with CsOH (50 nM free Ca2+).
###end p 74
###begin title 75
Analysis of fold change in channel activity
###end title 75
###begin p 76
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Dhaka1">[34]</xref>
Methods were similar to those described in [34]. To determine the fold change in control channel activity in the presence of agonist, blank sweeps (sweeps containing no TRP channel openings in the absence or presence of agonist) were used to determine the "leak"-subtracted control and agonist-induced level of activity at +120 mV (ramp protocol) or +100 mV (step protocol). The fold-change in activity was calculated by measuring the TRP-mediated current obtained by averaging consecutive traces acquired 1 to 2 min prior to agonist addition and during the maximal effect of agonist. Baseline currents were stable (<5% change in basal current) throughout the measurements.
###end p 76
###begin title 77
Excised or cell-attached patch clamp data analysis
###end title 77
###begin p 78
###xml 145 146 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Data in all figures and text are shown as mean +/- S.E.M. Statistical significance of the fold change in activity was evaluated using one sample t-test in combination with the Wilcoxon rank sum non-parametric test.
###end p 78
###begin title 79
Behavioral Assays
###end title 79
###begin p 80
###xml 68 72 <span type="species:ncbi:10090">mice</span>
All experiments involving animals were conducted on littermate male mice 6-16 weeks old with the approval of The Scripps Research Institute Animal Research Committee. Animals were acclimated for an about one hour in the testing environment prior to experiments unless otherwise stated. Experimenters were blind to genotype.
###end p 80
###begin title 81
Animals
###end title 81
###begin p 82
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 267 273 267 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Jul</sup>
###xml 262 273 262 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trpv1<sup>tm1Jul</sup></italic>
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
All the genetically modified animals were tested and compared with their control (wildtype or double heterozygote) littermates. C57BL6/J mice were used only when comparing between wildtype animals. TRPV1-/- mice were obtained from Jackson Laboratories (B6.129S4-Trpv1tm1Jul/J) backcrossed to C57BL6/J at least 10 generations. TRPA1-/- mice were on mixed genetic background between C57BL6/J and 129/Ola (derived from E14 ES cell) and were kindly provided by Dr. David Corey (Harvard University).
###end p 82
###begin title 83
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Breeding strategy for TRPV1-/- TRPA1-/- double deficient animals
###end title 83
###begin p 84
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 147 150 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 253 256 253 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 264 267 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 342 345 342 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 372 375 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
TRPV1 and TRPA1 double knockout animals were obtained as follows (V1:TRPV1, A1:TRPA1). First V1-/- and A1-/- animals were mated to generate V1+/-A1+/- animals. V1+/-A1+/- animals were then mated with each other to produce V1+/-A1+/-, V1+/-A1-/-, V1-/-A1+/-, and V1-/-A1-/- animals. Finally, littermates from mating pairs of V1+/-A1+/- with V1-/-A1-/- or V1+/-A1-/- with V1-/-A1+/- were used for the behavioral assays.
###end p 84
###begin title 85
Thermal hyperalgesia (hargreaves)
###end title 85
###begin p 86
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007596-Moqrich1">[57]</xref>
Thermal hyperalgesia assay was performed as described [57] using a Plantar IR Analgesia Meter (Ugo Basile 7370 Plantar Test). Baseline responses were measured one day prior to the administration of SNAP. Responses were measured post-injection in to the skin of left hindpaws with 10 microl of 25 mM SNAP or vehicle solution. Paw withdrawal latency to thermal stimuli (three stimuli per time point) were measured and averaged at 30 minutes post injection. 25 mM SNAP solution in PBS was prepared right before injection by dissolving 2.5 M stock in DMSO. Stock solution of SNAP was kept in dark.
###end p 86
###begin title 87
Paw injection
###end title 87
###begin p 88
NOC7: After acclimation, animals were first injected with 10 microl of forskolin and m-3M3FBS at 1 mM each (stock in ethanol). 5 min after the first injection, they were injected into the same spot with 10 microl of NOC7 at 25 mM (NOC7 was dissolved in 0.01 N NaOH, and then further dissolved into 1X PBS and 10 mM HEPES). Time spent on pain behavior (flicking, licking, and lifting injected paw) was recorded for 10 min after injection of NOC7.
###end p 88
###begin p 89
NOR3: After acclimation, animals were first injected with 10 microl of forskolin and m-3M3FBS at 1 mM each (stock in DMSO). 15 min after the first injection, they were injected into the same spot with 10 microl of NOR3 at 1.5 mM (1% DMSO as vehicle). Time spent on pain behavior (flicking, licking, and lifting injected paw) was recorded for 10 min after injection of NO donor.
###end p 89
###begin p 90
Initially, forskolin and m-3M3FBS ("sensitizers") dissolved as stock solutions in DMSO were used for experiment using NOR3. Since DMSO injection causes acute pain behavior (solution of "sensitizers" contained 12% DMSO, which caused approximately60 sec pain behavior over 10 min after injection), we waited 15 min until cessation of the pain behavior. Subsequent experiments were performed using ethanol as a vehicle for the sensitizers when it was determined that ethanol produced no acute pain behavior. NOC7 was injected 5 min after sensitizer injection and behavior was determined.
###end p 90
###begin title 91
Site-Directed Mutagenesis
###end title 91
###begin p 92
Point mutations were introduced using QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to manufacturer's instructions.
###end p 92
###begin title 93
Chemicals
###end title 93
###begin p 94
SNAP, Fura-2, and DAF-FM were purchased from Invitrogen. NOR3 and NOC7 were purchased from EMD Biosciences. BCTC and AP-18 were purchased from Biomol. All the other chemicals (capsaicin, mustard oil, forskolin, pCPT-cGMP, ruthenium red, ATP, NAP, potassium chloride, L-NAME, D-NAME, BH4, and m-3M3FBS) were purchased from Sigma-Aldrich. NO donors and BH4 were kept in the dark and prepared immediately before use.
###end p 94
###begin title 95
Data Analysis
###end title 95
###begin p 96
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 196 202 196 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g003">Fig. 3</xref>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 252 258 252 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g005">Fig. 5</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007596-g006">6A</xref>
Error bars represents S.E.M. for all figures and tables. P-values are based on one sample t-test in combination with the Wilcoxon rank sum non-parametric test for electrophysiological recordings (Fig. 3), on Student's t-test for comparing two samples (Fig. 5, 6A), and on one way ANOVA followed by Tukey's honest significance test for the remainder of experiments. * p<0.05, ** p<0.01, *** p<0.001
###end p 96
###begin p 97
###xml 163 167 <span type="species:ncbi:10090">mice</span>
We thank T. Rosenbaum (Instituto de Fisiologia Celular, Mexico) for generously providing TRPV1 mutants; Dr. D. Corey (Harvard University), for the TRPA1-deficient mice; Dr. C. Woolf, Dr. A. Binshtok, and Y. Ibarra (Harvard University) for technical help on BH4 experiments; B. Xiao, H. Hu, M. Bandell, and V. Uzzell, for cDNAs; M. Schmidt, for valuable input; and the rest of the Patapoutian lab, for helpful comments.
###end p 97
###begin title 98
References
###end title 98
###begin article-title 99
Biochemistry of nitric oxide and its redox-activated forms.
###end article-title 99
###begin article-title 100
Nitric oxide: a physiologic messenger.
###end article-title 100
###begin article-title 101
Nitric oxide (NO) and nociceptive processing in the spinal cord.
###end article-title 101
###begin article-title 102
Nitric oxide-sensitive guanylyl cyclase: structure and regulation.
###end article-title 102
###begin article-title 103
Protein S-nitrosylation: purview and parameters.
###end article-title 103
###begin article-title 104
cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO.
###end article-title 104
###begin article-title 105
Nitric oxide in damage, disease and repair of the peripheral nervous system.
###end article-title 105
###begin article-title 106
###xml 163 169 <span type="species:ncbi:9913">bovine</span>
The distribution and co-localization of immunoreactivity to nitric oxide synthase, vasoactive intestinal polypeptide and substance P within nerve fibres supplying bovine and porcine female genital organs.
###end article-title 106
###begin article-title 107
Increased expression of neuronal nitric oxide synthase in dorsal root ganglion neurons after systemic capsaicin administration.
###end article-title 107
###begin article-title 108
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice.
###end article-title 108
###begin article-title 109
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice.
###end article-title 109
###begin article-title 110
Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex.
###end article-title 110
###begin article-title 111
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse.
###end article-title 111
###begin article-title 112
###xml 28 34 <span type="species:ncbi:9606">humans</span>
Nitric oxide evokes pain in humans on intracutaneous injection.
###end article-title 112
###begin article-title 113
###xml 158 162 <span type="species:ncbi:10116">rats</span>
Application of nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester, on injured nerve attenuates neuropathy-induced thermal hyperalgesia in rats.
###end article-title 113
###begin article-title 114
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Nitric oxide signaling in pain and nociceptor sensitization in the rat.
###end article-title 114
###begin article-title 115
Modulation of acute inflammation by endogenous nitric oxide.
###end article-title 115
###begin article-title 116
Evidence that endogenous nitric oxide modulates oedema formation induced by substance P.
###end article-title 116
###begin article-title 117
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.
###end article-title 117
###begin article-title 118
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
###end article-title 118
###begin article-title 119
Activation of transient receptor potential ankyrin 1 by hydrogen peroxide.
###end article-title 119
###begin article-title 120
Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators.
###end article-title 120
###begin article-title 121
Unpublished observations.
###end article-title 121
###begin article-title 122
cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I.
###end article-title 122
###begin article-title 123
Substituted cGMP analogs can act as selective agonists of the rod photoreceptor cGMP-gated cation channel.
###end article-title 123
###begin article-title 124
TRP channel activation by reversible covalent modification.
###end article-title 124
###begin article-title 125
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
###end article-title 125
###begin article-title 126
###xml 86 91 <span type="species:ncbi:4679">onion</span>
###xml 96 102 <span type="species:ncbi:4682">garlic</span>
A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic.
###end article-title 126
###begin article-title 127
Bimodal action of menthol on the transient receptor potential channel TRPA1.
###end article-title 127
###begin article-title 128
Mechanistic aspects of the reactions of nitric oxide with transition-metal complexes.
###end article-title 128
###begin article-title 129
Zinc activates damage-sensing TRPA1 ion channels.
###end article-title 129
###begin article-title 130
From chills to chilis: mechanisms for thermosensation and chemesthesis via thermoTRPs.
###end article-title 130
###begin article-title 131
TRPC channel activation by extracellular thioredoxin.
###end article-title 131
###begin article-title 132
TRPV1 is activated by both acidic and basic pH.
###end article-title 132
###begin article-title 133
A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition.
###end article-title 133
###begin article-title 134
N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.
###end article-title 134
###begin article-title 135
Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin.
###end article-title 135
###begin article-title 136
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Impaired nociception and pain sensation in mice lacking the capsaicin receptor.
###end article-title 136
###begin article-title 137
ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures.
###end article-title 137
###begin article-title 138
TRPA1 Desensitization in Sensory Neurons is Agonist- Dependent and Regulated by TRPV1-Directed Internalization.
###end article-title 138
###begin article-title 139
Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain.
###end article-title 139
###begin article-title 140
Identification of a compound that directly stimulates phospholipase C activity.
###end article-title 140
###begin article-title 141
Gating of TRP channels: a voltage connection?
###end article-title 141
###begin article-title 142
Bidirectional shifts of TRPM8 channel gating by temperature and chemical agents modulate the cold sensitivity of mammalian thermoreceptors.
###end article-title 142
###begin article-title 143
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Intracellular alkalization causes pain sensation through activation of TRPA1 in mice.
###end article-title 143
###begin article-title 144
Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal.
###end article-title 144
###begin article-title 145
Transient receptor potential channels: targeting pain at the source.
###end article-title 145
###begin article-title 146
Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.
###end article-title 146
###begin article-title 147
Nitric oxide function in the skin.
###end article-title 147
###begin article-title 148
Nitrooleic acid, an Endogenous Product of Nitrative Stress, Activates Nociceptive Sensory Nerves via the Direct Activation of TRPA1.
###end article-title 148
###begin article-title 149
Neurobiology of migraine.
###end article-title 149
###begin article-title 150
###xml 116 122 <span type="species:ncbi:9606">humans</span>
The TRPV1 antagonist SB705498 attenuates TRPV1 receptor-mediated activity and inhibits inflammatory hyperalgesia in humans: results from a Phase 1 study.
###end article-title 150
###begin article-title 151
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity.
###end article-title 151
###begin article-title 152
###xml 142 146 <span type="species:ncbi:10090">mice</span>
Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice.
###end article-title 152
###begin article-title 153
TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.
###end article-title 153
###begin article-title 154
Mechanisms of disease: involvement of the urothelium in bladder dysfunction.
###end article-title 154
###begin article-title 155
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin.
###end article-title 155
###begin article-title 156
TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction.
###end article-title 156
###begin article-title 157
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents.
###end article-title 157
###begin p 158
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 158
###begin p 159
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by grants from the US National Institutes of Health (R01NS049104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 159

